Posted on 2/24/21
Orna Therapeutics Raises $100M
Orna Therapeutics, a Cambridge, Mass.-based biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics (oRNAs), completed an $80m Series . . .
Posted on 2/24/21
Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial Results
CAMBRIDGE, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, . . .
Posted on 2/24/21
Why Moderna Stock Tanked on Tuesday
What happenedShares of Moderna (NASDAQ:MRNA) fell by almost 6% on Tuesday. While the company's mRNA-1273 remains one of only two coronavirus vaccines authorized by the Food . . .
Posted on 2/23/21
Peak Physical Therapy & Sports Performance Expands Aquatic Therapy Program at the Weymouth Club
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive treatment in orthopedic, spine and sports medicine specialties, is . . .
Posted on 2/23/21
Battery Ventures-backed SPT Labtech acquires Apricot Designs and BioMicroLab
Battery Ventures, a global, technology-focused investment firm, recently completed the acquisitions of Apricot Designs and BioMicroLab, integrating the two companies into its sample-preparation platform company SPT . . .
Posted on 2/23/21
Beam Therapeutics Acquires Guide Therapeutics
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced it has completed the acquisition of Guide Therapeutics, Inc.,
Posted on 2/23/21
Rubius Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
CAMBRIDGE Mass., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an . . .
Posted on 2/22/21
ABclonal Biotechnology Raises $93 Million Series C
ABclonal Biotechnology, a global life science tools and services provider, recently completed its $92.9 million Series C financing led by Sequoia Capital China and healthcare-focused
Posted on 2/22/21
Cullinan Management Announces Business Update
CAMBRIDGE, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Cullinan Management, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and . . .
Posted on 2/22/21
ABclonal Biotechnology Closes $93M Series C
ABclonal Biotechnology, a Woburn, Mass.-based global life science tools and services provider, completed its $92.9m Series C financing.
Posted on 2/22/21
Here's What I'll Be Looking for in Moderna's Earnings Report Next Week
Moderna (NASDAQ:MRNA) has spent the past two months producing and shipping its much-awaited coronavirus vaccine. But we won't see too much of an impact from its . . .
Posted on 2/22/21
Is Biogen Stock a Buy?
Investing in healthcare stocks can be risky. That's true in part because it only takes one or two drugs to dictate the success of an entire . . .
Posted on 2/22/21
What Should Vertex Pharmaceuticals Buy With its $6.6 Billion Stash?
Vertex Pharmaceuticals (NASDAQ:VRTX) has $6.6 billion in the bank and continues to generate more cash flow each quarter. While Vertex has some early stage drugs that . . .
Posted on 2/22/21
Is Moderna Stock a Buy?
Few companies can legitimately claim to have made a profound impact on human history. Moderna (NASDAQ:MRNA) is arguably an exception. The biotech's rapid development of a . . .
Posted on 2/18/21
Thermo Fisher Scientific Recognized with Six CMO Leadership Awards
Thermo Fisher Scientific, the world leader in serving science, today announced it has won six awards in the annual CMO Leadership Awards. The awards, presented by . . .
Posted on 2/18/21
LabCentral Announces $22.4 Million in Committed Funding for LabCentral 238
LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, today announced a total of $22.4 million in sponsorship commitments for LabCentral . . .
Posted on 2/18/21
Phio Pharmaceuticals Closes of $7.7 Million Registered Direct Offering of Common Stock
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic platform, today announced . . .
Posted on 2/18/21
IQVIA Prices of Offering of Senior Notes
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc., priced an offering of €1,450,000,000 . . .
Posted on 2/18/21
Infinity Closes of $92 Million Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (Nasdaq: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic . . .
Posted on 2/18/21
‘COVID-19 Business School’ from Virtual Is Now Accepting All Students
Virtual, Inc. opened the doors to CEO Andy Freed's COVID-19 Business School,’ a master class to be held online today at 2 p.m. Eastern. Interested students . . .
Posted on 2/18/21
Arch Therapeutics Closes of $6.9 Million Private Placement
FRAMINGHAM, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH), developer of novel self-assembling wound care and biosurgical devices, today announced it has . . .
Posted on 2/18/21
Safest States During COVID-19 – Updated WalletHub Study
With only 5% of the population fully vaccinated against COVID-19 as of February 17, and vaccination being an essential component for full reopening of the economy, . . .
Posted on 2/17/21
Codiak Closes $66.4M Public Offering
CAMBRIDGE, Mass., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as . . .
Posted on 2/17/21
Phio Pharmaceuticals Closes $7.7M Registered Direct Offering of Common Stock
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced . . .
Posted on 2/17/21
Thermo Fisher Scientific Acquires Cell Sorting Technology from Propel Labs
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced it has acquired cell sorting technology assets from Propel Labs, a wholly-owned subsidiary . . .
Boston
